Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.

Barbareschi M, Cantaloni C, Del Vescovo V, Cavazza A, Monica V, Carella R, Rossi G, Morelli L, Cucino A, Silvestri M, Tirone G, Pelosi G, Graziano P, Papotti M, Dalla Palma P, Doglioni C, Denti MA.

Am J Clin Pathol. 2011 Nov;136(5):773-82. doi: 10.1309/AJCPYY79XAGRAYCJ.

PMID:
22031317
[PubMed - indexed for MEDLINE]
Free Article
2.

Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.

Noh S, Shim H.

Lung Cancer. 2012 Apr;76(1):51-5. doi: 10.1016/j.lungcan.2011.09.008. Epub 2011 Oct 5.

PMID:
21978426
[PubMed - indexed for MEDLINE]
3.

miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.

Del Vescovo V, Cantaloni C, Cucino A, Girlando S, Silvestri M, Bragantini E, Fasanella S, Cuorvo LV, Palma PD, Rossi G, Papotti M, Pelosi G, Graziano P, Cavazza A, Denti MA, Barbareschi M.

Am J Surg Pathol. 2011 Feb;35(2):268-75. doi: 10.1097/PAS.0b013e3182068171.

PMID:
21263248
[PubMed - indexed for MEDLINE]
4.

Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.

Mukhopadhyay S, Katzenstein AL.

Am J Surg Pathol. 2011 Jan;35(1):15-25. doi: 10.1097/PAS.0b013e3182036d05.

PMID:
21164283
[PubMed - indexed for MEDLINE]
5.

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.

Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH.

Clin Cancer Res. 2010 Jan 15;16(2):610-9. doi: 10.1158/1078-0432.CCR-09-2638. Epub 2010 Jan 12.

PMID:
20068099
[PubMed - indexed for MEDLINE]
Free Article
6.

Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.

Khayyata S, Yun S, Pasha T, Jian B, McGrath C, Yu G, Gupta P, Baloch Z.

Diagn Cytopathol. 2009 Mar;37(3):178-83. doi: 10.1002/dc.20975.

PMID:
19170169
[PubMed - indexed for MEDLINE]
7.

Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology.

Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G.

Virchows Arch. 2014 Jan;464(1):61-8. doi: 10.1007/s00428-013-1501-6. Epub 2013 Nov 13.

PMID:
24221342
[PubMed - indexed for MEDLINE]
8.

Histopathologic classification of lung cancer: Relevance of cytokeratin and TTF-1 immunophenotyping.

Johansson L.

Ann Diagn Pathol. 2004 Oct;8(5):259-67.

PMID:
15494931
[PubMed - indexed for MEDLINE]
9.

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

Nicholson AG, Gonzalez D, Shah P, Pynegar MJ, Deshmukh M, Rice A, Popat S.

J Thorac Oncol. 2010 Apr;5(4):436-41. doi: 10.1097/JTO.0b013e3181c6ed9b.

PMID:
20068475
[PubMed - indexed for MEDLINE]
10.

Large cell carcinoma of the lung: an endangered species?

Pardo J, Martinez-Peñuela AM, Sola JJ, Panizo A, Gúrpide A, Martinez-Peñuela JM, Lozano MD.

Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):383-92. doi: 10.1097/PAI.0b013e31819bfd59.

PMID:
19444077
[PubMed - indexed for MEDLINE]
11.

TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.

Rossi G, Marchioni A, Milani M, Scotti R, Foroni M, Cesinaro A, Longo L, Migaldi M, Cavazza A.

Am J Clin Pathol. 2004 Dec;122(6):884-93.

PMID:
15595193
[PubMed - indexed for MEDLINE]
Free Article
12.

Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.

Rekhtman N, Tafe LJ, Chaft JE, Wang L, Arcila ME, Colanta A, Moreira AL, Zakowski MF, Travis WD, Sima CS, Kris MG, Ladanyi M.

Mod Pathol. 2013 Apr;26(4):511-22. doi: 10.1038/modpathol.2012.195. Epub 2012 Nov 30. Erratum in: Mod Pathol. 2014 Jan;27(1):163.

PMID:
23196793
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.

Loo PS, Thomas SC, Nicolson MC, Fyfe MN, Kerr KM.

J Thorac Oncol. 2010 Apr;5(4):442-7. doi: 10.1097/JTO.0b013e3181d40fac.

PMID:
20195168
[PubMed - indexed for MEDLINE]
14.

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung.

Monica V, Ceppi P, Righi L, Tavaglione V, Volante M, Pelosi G, Scagliotti GV, Papotti M.

Mod Pathol. 2009 May;22(5):709-17. doi: 10.1038/modpathol.2009.30. Epub 2009 Mar 13.

PMID:
19287461
[PubMed - indexed for MEDLINE]
Free Article
15.

P63 expression in lung carcinoma: a tissue microarray study of 408 cases.

Au NH, Gown AM, Cheang M, Huntsman D, Yorida E, Elliott WM, Flint J, English J, Gilks CB, Grimes HL.

Appl Immunohistochem Mol Morphol. 2004 Sep;12(3):240-7.

PMID:
15551738
[PubMed - indexed for MEDLINE]
16.

Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.

Tsuta K, Tanabe Y, Yoshida A, Takahashi F, Maeshima AM, Asamura H, Tsuda H.

J Thorac Oncol. 2011 Jul;6(7):1190-9. doi: 10.1097/JTO.0b013e318219ac78.

PMID:
21623236
[PubMed - indexed for MEDLINE]
17.

Reliability of cytologic diagnosis of early lung cancer.

Vazquez MF, Koizumi JH, Henschke CI, Yankelevitz DF.

Cancer. 2007 Aug 25;111(4):252-8.

PMID:
17614298
[PubMed - indexed for MEDLINE]
Free Article
18.

Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.

Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.

Cancer. 2001 Oct 25;93(5):330-6.

PMID:
11668468
[PubMed - indexed for MEDLINE]
19.

Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles.

Jones MH, Virtanen C, Honjoh D, Miyoshi T, Satoh Y, Okumura S, Nakagawa K, Nomura H, Ishikawa Y.

Lancet. 2004 Mar 6;363(9411):775-81.

PMID:
15016488
[PubMed - indexed for MEDLINE]
20.

Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma.

Xu JB, Bao Y, Liu X, Liu Y, Huang S, Wang JC.

Lung Cancer. 2007 Oct;58(1):36-43. Epub 2007 Jun 12.

PMID:
17566598
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk